Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study

Fig. 1

a Enrollment and primary outcome of induction treatment at week 24. Each spot represents one patient. b Changes of proteinuria during a 24-week follow-up. c Estimated GFR (eGFR) during follow-up, calculated by the EPI formula. d Outcomes of maintenance treatment for responded patients since week 24. CR, complete remission; PR, partial remission; AE, adverse event

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us